Tamoxifen may Help Reduce Breast Cancer Risk Among High-Risk Patients

by Kathy Jones on  April 16, 2013 at 10:08 PM Cancer News
RSS Email Print This Page Comment
Font : A-A+

A new study published in the Annals of Internal Medicine suggests that women who have a high risk of developing breast cancer can benefit by using the drugs tamoxifen and raloxifene (Evista).
 Tamoxifen may Help Reduce Breast Cancer Risk Among High-Risk Patients
Tamoxifen may Help Reduce Breast Cancer Risk Among High-Risk Patients

Researchers led by Dr Heidi Nelson from Oregon Health and Science University in Portland analyzed studies which compared the instances of breast cancer among women placebo and  tamoxifen.

The researchers found that around 23.5 women per 1,000 women developed breast cancer among those who took placebo over a period of five years compared to 16.5 percent 1,000 women who took tamoxifen during the same period.

"Tamoxifen is more effective at reducing breast cancer risk, but it has more side effects. Some women have side effects that are not life-threatening but they are uncomfortable and not minor, and cause them to stop medications, such as vaginal discharge, dryness, itching, leg cramps", Nelson said.



Source: Medindia

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

Women and Cancer Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Breast Cancer Facts Cancer Facts Cancer Tattoos A Body Art Breasts - Structures and Types 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive